Athletes First and Revlon team during Super Bowl week
Agency's 100,000-square-foot hospitality experience to host Revlon's beauty bar and American Crew's grooming lounge during three-day Big Game event for clients, influencers, and guests.
Agency's 100,000-square-foot hospitality experience to host Revlon's beauty bar and American Crew's grooming lounge during three-day Big Game event for clients, influencers, and guests.
These scrubs deliver deep cleansing, exfoliation, and hydration for healthier, smoother skin.
On the heels of its 10th anniversary, the brand’s iconic hydro boost collection is revealing a juicy, fresh take.
This update reflects advances in scientific research since the previous edition in 2014.
The Somerset, N.J. facility encompasses over 50,000 sq ft of cGMP manufacturing space and is home to over 200 skilled scientists and technicians.
Journavx is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years.
With over 20 years in consumer goods and beauty, Christina Fair brings extensive expertise to her new role.
As the countdown to the Big Game begins, snack lovers can anticipate a commercial that is as memorable as the iconic Pringles crunch.
New leadership position focuses on driving innovation, growth and service excellence.
The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.
The list is compiled of the 650 highest-revenue companies from 51 industries across 30 countries.
Clinical trials showed Ozempic slowed kidney disease progression and lowered risks of kidney failure and cardiovascular events.
Company raises fiscal year 2025 outlook.
“The new sleek cans and bold designs highlight a reinvented brand expected to appeal to new consumers seeking delicious and refreshing fruit flavor combinations to enjoy wherever their escape takes them.”
Sirolimus oral solution is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged greater or equal to 13 years, receiving renal transplants.
Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards.